| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Lidocaine 5% plasters |
| Brand | Versatis® |
| Indication | For the symptomatic relief of neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia, PHN). |
| Assessment Process | |
| Rapid review commissioned | 09/09/2010 |
| Rapid review completed | 22/10/2010 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Recommended. |
| Full pharmacoeconomic assessment commissioned by HSE | 10/06/2015 |
| NCPE assessment completed | 24/09/2015 |
| NCPE assessment outcome | Reimbursement Not Recommended |
The NCPE concludes that the cost effectiveness of the 5% lidocaine plaster has not been demonstrated.